GEOF: what changed
What changed
GEOF
NACE 47.730, Retail sale of pharmaceutical products
filed annual accounts (NBB)
Net result for the year
€41,098
2024 · €43,185-€2,087
Equity
€1.3m
2024 · €1.3m+€41,098
Cash
€63,939
2024 · €53,034+€10,905
Balance sheet total
€2.1m
2024 · €2.1m+€3,413
Largest movements
Assets
- Current investments +€37,758
up €37,758 (+6.9%), from €546,709 to €584,467
- Receivables within one year -€31,807
down €31,807 (-54.5%), from €58,312 to €26,504
of which Other amounts receivable: -€31,807
Equity and liabilities
- Reserves +€41,098
up €41,098 (+5.7%), from €722,161 to €763,259
of which Distributable reserves: +€41,098
- Current portion of long-term debt -€37,169
no longer reported in 2025 (was €37,169)
Income statement
- Gross operating margin -€35,837
down €35,837 (-26.1%), from €137,350 to €101,513
- Financial charges -€19,529
down €19,529 (-38.5%), from €50,743 to €31,214
of which Financial charges: -€19,528
- Taxes -€8,827
down €8,827 (-29.8%), from €29,646 to €20,820
- Financial income +€5,402
up €5,402 (+862%), from €627 to €6,029
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Result 2024
€43,185
Gross operating margin
-€35,837
Staff costs
-€7
Depreciation
+€0
Financial income
+€5,402
Financial charges
+€19,529
Taxes
+€8,827
Result 2025
€41,098
raises the resultlowers the result
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
From operations
+€85,831
Investment
-€37,758
Financing
-€37,169
Cash 2024
€53,034
From operations (derived)
+€85,831
Net result for the year
+€41,098
Depreciation
+€13,442
Receivables within one year
+€31,807
Trade debts
+€2,437
Tax, wage and social debts
+€8,659
Other debts
-€11,611
Investment (derived)
-€37,758
Current investments
-€37,758
Financing
-€37,169
Current portion of long-term debt
-€37,169
Cash 2025
€63,939
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €2,101,429 | €2,104,842 | +€3,413 | +0.2% |
| Fixed assets | 21/28 | €1,443,375 | €1,429,933 | -€13,442 | -0.9% |
| Intangible fixed assets | 21 | €13,442 | - | -€13,442 | |
| Financial fixed assets | 28 | €1,429,933 | €1,429,933 | = | 0.0% |
| Current assets | 29/58 | €658,055 | €674,910 | +€16,855 | +2.6% |
| Amounts receivable within one year | 40/41 | €58,312 | €26,504 | -€31,807 | -54.5% |
| Trade receivables | 40 | €18,150 | €18,150 | = | 0.0% |
| Other amounts receivable | 41 | €40,162 | €8,354 | -€31,807 | -79.2% |
| Current investments | 50/53 | €546,709 | €584,467 | +€37,758 | +6.9% |
| Cash at bank and in hand | 54/58 | €53,034 | €63,939 | +€10,905 | +20.6% |
| Total equity and liabilities | 10/49 | €2,101,429 | €2,104,842 | +€3,413 | +0.2% |
| Equity | 10/15 | €1,267,716 | €1,308,815 | +€41,098 | +3.2% |
| Contributions | 10/11 | €531,500 | €531,500 | = | 0.0% |
| Capital | 10 | €531,500 | €531,500 | = | 0.0% |
| Issued capital | 100 | €531,500 | €531,500 | = | 0.0% |
| Reserves | 13 | €722,161 | €763,259 | +€41,098 | +5.7% |
| Non-distributable reserves | 130/1 | €53,150 | €53,150 | = | 0.0% |
| Legal reserve | 130 | €53,150 | €53,150 | = | 0.0% |
| Distributable reserves | 133 | €669,011 | €710,109 | +€41,098 | +6.1% |
| Profit (loss) carried forward | 14 | €14,055 | €14,055 | = | 0.0% |
| Amounts payable | 17/49 | €833,713 | €796,028 | -€37,685 | -4.5% |
| Amounts payable within one year | 42/48 | €833,713 | €796,028 | -€37,685 | -4.5% |
| Current portion of amounts payable after more than one year | 42 | €37,169 | - | -€37,169 | |
| Trade debts | 44 | €168 | €2,604 | +€2,437 | +1,453% |
| Suppliers | 440/4 | €168 | €2,604 | +€2,437 | +1,453% |
| Taxes, remuneration and social security | 45 | €39,990 | €48,648 | +€8,659 | +21.7% |
| Taxes | 450/3 | €39,990 | €48,648 | +€8,659 | +21.7% |
| Other amounts payable | 47/48 | €756,387 | €744,775 | -€11,611 | -1.5% |
| Remuneration, social security and pensions | 62 | €960 | €968 | +€7 | +0.8% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €13,442 | €13,442 | -€0 | 0.0% |
| Gross operating margin | 9900 | €137,350 | €101,513 | -€35,837 | -26.1% |
| Operating profit (loss) | 9901 | €122,948 | €87,104 | -€35,844 | -29.2% |
| Financial income | 75/76B | €627 | €6,029 | +€5,402 | +862% |
| Recurring financial income | 75 | €627 | €6,029 | +€5,402 | +862% |
| Financial charges | 65/66B | €50,743 | €31,214 | -€19,529 | -38.5% |
| Recurring financial charges | 65 | €50,712 | €31,184 | -€19,528 | -38.5% |
| Non-recurring financial charges | 66B | €31 | €30 | -€1 | -4.5% |
| Profit (loss) for the period before taxes | 9903 | €72,831 | €61,918 | -€10,913 | -15.0% |
| Income taxes | 67/77 | €29,646 | €20,820 | -€8,827 | -29.8% |
| Profit (loss) for the period | 9904 | €43,185 | €41,098 | -€2,087 | -4.8% |
| Transfer from tax-exempt reserves | 789 | €71,200 | - | -€71,200 | |
| Profit (loss) for the period to be appropriated | 9905 | €114,385 | €41,098 | -€73,287 | -64.1% |
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Compare this company with its sector.Sector benchmark
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 March 2024 and 31 March 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 2 November 2026 via checked.be.